Identification of biomarkers in myocardial hypertrophy and fibrosis via integrated transcriptomic and phosphoproteomic profiling
Kang Luo, Yangguang Ma, Yayong Zhang, Yunfeng Zi, Guangyuan Guo, Xingyuan Chen, Wenjuan Feng, Qifan Jing, Lin Li, Shen Han, Bingrong Zheng · 2026
Read Identification of biomarkers in myocardial hypertrophy and fibrosis via integrated transcriptomic and phosphoproteomic profiling by Kang Luo, Yangguang Ma, Yayong Zhang, Yunfeng Zi, Guangyuan Guo, Xingyuan Chen, Wenjuan Feng, Qifan Jing, Lin Li, Shen Han, Bingrong Zheng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13243507.txt.
Description
Myocardial hypertrophy and fibrosis (MHF) are key structural changes in adverse cardiac remodeling. They are commonly observed in hypertension, metabolic disorders, and cardiomyopathies. These processes contribute to heart failure and sudden death, yet their molecular mechanisms remain unclear. We established in vivo and in vitro models of MHF and performed transcriptomic and label-free phosphoproteomic sequencing.
Catalog record
| CREATOR | Kang Luo, Yangguang Ma, Yayong Zhang, Yunfeng Zi, Guangyuan Guo, Xingyuan Chen, Wenjuan Feng, Qifan Jing, Lin Li, Shen Han, Bingrong Zheng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 77 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |